Trials / Terminated
TerminatedNCT04059445
Mandibular Furcation II Regeneration
Biphasic Calcium Phosphate and a Collagen Membrane or Biphasic Calcium Phosphate and Enamel Matrix Proteins, in the Regenerative Treatment of Furcation Grade II Defects
- Status
- Terminated
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 5 (actual)
- Sponsor
- University of Oslo · Academic / Other
- Sex
- All
- Age
- 20 Years
- Healthy volunteers
- Accepted
Summary
Teeth with furcation grade II defects will be treated with open flap debridement and regenerative therapy with biphasic calcium phosphate combined with either enamel matrix proteins or a collagen membrane.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Biphasic calcium phosphate (Straumann Bone Ceramic) + collagen membrane (Straumann Jason Membrane) | Regenerative therapy with biphasic calcium phosphate + collagen membrane. |
| DRUG | Biphasic calcium phosphate (Straumann Bone Ceramic) + enamel matrix proteins (Straumann Emdogain) | Regenerative therapy with biphasic calcium phosphate + enamel matrix proteins. |
Timeline
- Start date
- 2019-10-15
- Primary completion
- 2023-11-27
- Completion
- 2023-11-27
- First posted
- 2019-08-16
- Last updated
- 2023-11-30
Locations
1 site across 1 country: Norway
Source: ClinicalTrials.gov record NCT04059445. Inclusion in this directory is not an endorsement.